NASDAQ:LTGO | Income Statement | Latigo Biotherapeutics, Inc.

Complete source-backed income-statement history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$21.23M$25.81M-$25.81M$11,000.00$0.00-$25.8M-$27.59-$27.59935,025935,025
2026-03-31-$22.96M
2025-06-30$22.92M$25.75M-$25.75M-$90,000.00$0.00-$25.84M-$36.52-$36.52707,465707,465
2025-03-31-$20.95M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares